Literature DB >> 7543899

Epitopic regions for antibodies against tumor necrosis factor alpha. Analysis by synthetic peptide mapping.

K Yone1, S Bajard, N Tsunekawa, J Suzuki.   

Abstract

The location of biologically relevant epitopes on human tumor necrosis factor alpha (hTNF-alpha) was evaluated by testing the immunoreactivity of anti-TNF-alpha antibodies against 149 sequential, overlapping octamer peptides. A goat polyclonal antibody raised against recombinant hTNF-alpha, which neutralizes hTNF-alpha biological activities, reacted with oligopeptides corresponding to hTNF-alpha residues 7-11, 17-23, 30-39, 42-49, 106-112, and 135-142. A possible assembled epitopic region (residues 25, 27, and 144) for neutralizing murine monoclonal antibodies designated 11D7G4 and 9C4G5 was deduced from the fact that they bound to tripeptides, mimicking a discontinuous epitope. These antigenic regions wer found to include of adjoin poorly conserved amino acids and they were located in the turns between beta-sheets on the surface of the molecule. Three of the sequential epitopic regions and an assembled region were closely related to the receptor binding sites proposed in several other studies. These antibodies appear to neutralize TNF-alpha activities by directly masking receptor binding sites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543899     DOI: 10.1074/jbc.270.33.19509

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Mapping of the interleukin-10/interleukin-10 receptor combining site.

Authors:  U Reineke; R Sabat; H D Volk; J Schneider-Mergener
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

2.  Non-linear antigenic regions in epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha) studied by EGF-TGF alpha chimaeras.

Authors:  M L van de Poll; W van Rotterdam ; M M Gadellaa; C Stortelers; M J van Vugt ; E J van Zoelen
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

3.  Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα.

Authors:  W Mark Abbott; Melanie Snow; Sonia Eckersley; Jonathan Renshaw; Gareth Davies; Richard A Norman; Peter Ceuppens; Jerry Slootstra; Joris J Benschop; Yoshitomo Hamuro; Jessica E Lee; Peter Newham
Journal:  Biosci Rep       Date:  2013-08-23       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.